These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35653354)

  • 21. Alterations in the Salivary Proteome and N-Glycome of Sjögren's Syndrome Patients.
    Hall SC; Hassis ME; Williams KE; Albertolle ME; Prakobphol A; Dykstra AB; Laurance M; Ona K; Niles RK; Prasad N; Gormley M; Shiboski C; Criswell LA; Witkowska HE; Fisher SJ
    J Proteome Res; 2017 Apr; 16(4):1693-1705. PubMed ID: 28282148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soluble siglec-5 is a novel salivary biomarker for primary Sjogren's syndrome.
    Lee J; Lee J; Baek S; Koh JH; Kim JW; Kim SY; Chung SH; Choi SS; Cho ML; Kwok SK; Ju JH; Park SH
    J Autoimmun; 2019 Jun; 100():114-119. PubMed ID: 30922727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinct microRNA expression profiles in saliva and salivary gland tissue differentiate patients with primary Sjögren's syndrome from non-Sjögren's sicca patients.
    Sembler-Møller ML; Belstrøm D; Locht H; Pedersen AML
    J Oral Pathol Med; 2020 Nov; 49(10):1044-1052. PubMed ID: 32799333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Proteomics of Saliva in Sjögren's Syndrome.
    Katsiougiannis S; Wong DT
    Rheum Dis Clin North Am; 2016 Aug; 42(3):449-56. PubMed ID: 27431347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Salivary free light chains and salivary immunoglobulins as potential non-invasive biomarkers in primary Sjögren's syndrome.
    Sandhya P; Kabeerdoss J; Christudoss P; Arulraj R; Mandal SK; Janardana R; Chebbi PP; Ganesan MP; Mahasampath G; Danda D
    Int J Rheum Dis; 2022 Jan; 25(1):61-69. PubMed ID: 34791797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low-Dose Doxycycline Treatment Normalizes Levels of Some Salivary Metabolites Associated with Oral Microbiota in Patients with Primary Sjögren's Syndrome.
    Herrala M; Turunen S; Hanhineva K; Lehtonen M; Mikkonen JJW; Seitsalo H; Lappalainen R; Tjäderhane L; Niemelä RK; Salo T; Myllymaa S; Kullaa AM; Kärkkäinen O
    Metabolites; 2021 Sep; 11(9):. PubMed ID: 34564411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative proteomics of parotid saliva in primary Sjögren's syndrome.
    Ambatipudi KS; Swatkoski S; Moresco JJ; Tu PG; Coca A; Anolik JH; Gucek M; Sanz I; Yates JR; Melvin JE
    Proteomics; 2012 Oct; 12(19-20):3113-20. PubMed ID: 22888089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High salivary soluble L-selectin and interleukin-7 levels in Asian Indian patients with primary Sjögren's syndrome.
    Kabeerdoss J; Sandhya P; Mandal SK; Gowri M; Danda D
    Clin Rheumatol; 2016 Dec; 35(12):3063-3067. PubMed ID: 27620619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteomic Profiling of Saliva and Tears in Radiated Head and Neck Cancer Patients as Compared to Primary Sjögren's Syndrome Patients.
    Hynne H; Aqrawi LA; Jensen JL; Thiede B; Palm Ø; Amdal CD; Westgaard KL; Herlofson BB; Utheim TP; Galtung HK
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increase in acrolein-conjugated immunoglobulins in saliva from patients with primary Sjögren's syndrome.
    Hirose T; Saiki R; Uemura T; Suzuki T; Dohmae N; Ito S; Takahashi H; Ishii I; Toida T; Kashiwagi K; Igarashi K
    Clin Chim Acta; 2015 Oct; 450():184-9. PubMed ID: 26301996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigation of three potential autoantibodies in Sjogren's syndrome and associated MALT lymphoma.
    Cui L; Elzakra N; Xu S; Xiao GG; Yang Y; Hu S
    Oncotarget; 2017 May; 8(18):30039-30049. PubMed ID: 28404907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of salivary inflammatory biomarkers with primary Sjögren's syndrome.
    Moreno-Quispe LA; Serrano J; Virto L; Sanz M; Ramírez L; Fernández-Castro M; Hernández G; López-Pintor RM
    J Oral Pathol Med; 2020 Oct; 49(9):940-947. PubMed ID: 32538490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LC-MS-based serum metabolomics reveals a distinctive signature in patients with rheumatoid arthritis.
    Li J; Che N; Xu L; Zhang Q; Wang Q; Tan W; Zhang M
    Clin Rheumatol; 2018 Jun; 37(6):1493-1502. PubMed ID: 29442259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Levels of EGF and VEGF in patients with primary and secondary Sjögren's syndrome.
    Błochowiak KJ; Trzybulska D; Olewicz-Gawlik A; Sikora JJ; Nowak-Gabryel M; Kocięcki J; Witmanowski H; Sokalski J
    Adv Clin Exp Med; 2018 Apr; 27(4):455-461. PubMed ID: 29558032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum, but Not Saliva, CXCL13 Levels Associate With Infiltrating CXCL13+ Cells in the Minor Salivary Gland Lesions and Other Histologic Parameters in Patients With Sjögren's Syndrome.
    Chatzis L; Goules AV; Stergiou IE; Voulgarelis M; Tzioufas AG; Kapsogeorgou EK
    Front Immunol; 2021; 12():705079. PubMed ID: 34484201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Salivary and serum B-cell activating factor (BAFF) levels after hydroxychloroquine treatment in primary Sjögren's syndrome.
    Mumcu G; Biçakçigil M; Yilmaz N; Ozay H; Karaçayli U; Cimilli H; Yavuz S
    Oral Health Prev Dent; 2013; 11(3):229-34. PubMed ID: 23878841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fatigue in Sjögren's Syndrome: A Search for Biomarkers and Treatment Targets.
    Bodewes ILA; van der Spek PJ; Leon LG; Wijkhuijs AJM; van Helden-Meeuwsen CG; Tas L; Schreurs MWJ; van Daele PLA; Katsikis PD; Versnel MA
    Front Immunol; 2019; 10():312. PubMed ID: 30863411
    [No Abstract]   [Full Text] [Related]  

  • 38. Chemosensory dysfunction, Oral disorders and Oral health-related quality of life in patients with primary Sjögren's syndrome: comparative cross-sectional study.
    Šijan Gobeljić M; Milić V; Pejnović N; Damjanov N
    BMC Oral Health; 2020 Jul; 20(1):187. PubMed ID: 32620111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated
    Liu Z; Li F; Pan A; Xue H; Jiang S; Zhu C; Jin M; Fang J; Zhu X; Brown MA; Wang X
    Front Immunol; 2019; 10():795. PubMed ID: 31068931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. B7-H3 participates in human salivary gland epithelial cells apoptosis through NF-κB pathway in primary Sjögren's syndrome.
    Li P; Yang Y; Jin Y; Zhao R; Dong C; Zheng W; Zhang T; Li J; Gu Z
    J Transl Med; 2019 Aug; 17(1):268. PubMed ID: 31412888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.